|
TEMARIO DE SITIOS RELACIONADOS
- Enzimas como agentes inmunomodulares
- Enzimas como co-adyuvantes en terapia anti-cancerígena
- Enzimas como agentes anti-cancerígenos
- Enzimas para el tratamiento de enfermedades reumáticas
- Enzimas para el tratamiento del autismo
- Enzyme Deficit in the Human Body and its Role in Immune
Dysfunction and Toxic Overload: A review"
By Victor Ordonez (2006); A Monography submitted to the Program of
Nutritional Sciences in Partial Fulfillment of the requirement for the
Diploma of Nutritional Therapy. Stonebridge Associated Colleges, Bude,
Cornwall, United Kingdom
ENZIMAS COMO AGENTES INMUNOMODULADORES
1 - “The mechanisms of the curative action of systemic enzyme therapy”
Veremeenko KN, Dosenko VE, Kizim AI, Terzov AI. , Lik Sprava. 2000 Mar;(2):3-11
2 - “Pharmacological effects of oral enzyme combinations”
Stauder G. Cas Lek Cesk. 1995 Oct 4;134(19):620-4.
3 - “Systemic enzyme therapy in diseases of the vascular system”
Nouza K. Bratisl Lek Listy. 1995 Oct;96(10):566-9.
4 - “Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes”
Desser L, Rehberger A.
Oncology. 1990;47(6):475-7.
ENZIMAS COMO CO-ADYUVANTES EN TERAPIA ANTI-CANCERIGENA
5 - “Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers”
Gujral MS, Patnaik PM, Kaul R, Parikh HK, Conradt C, Tamhankar CP, Daftary GV.
Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S23-8.
6 - “Influence of a complementary treatment with oral enzymes on patients with colorectal cancers an epidemiological retrolective cohort study”
Popiela T, Kulig J, Hanisch J, Bock PR.
Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S55-63.
7 - “Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study”
Beuth J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B.
Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S45-54
8 - “ Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma”
Sakalova A, Bock PR, Dedik L, Hanisch J, Schiess W, Gazova S, Chabronova I, Holomanova D, Mistrik M, Hrubisko M.
Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S38-44.
ENZIMAS COMO AGENTES ANTI-CANCERIGENOS
9 - “Proenzyme therapy of cancer”
Novak JF, Trnka F.
Anticancer Res. 2005 Mar-Apr;25(2A):1157-77.
10 - “Systemic enzyme therapy in oncology: effect and mode of action”
Leipner J, Saller R.
Drugs. 2000 Apr;59(4):769-80
11 - “Density of adhesive proteins after oral administration of proteolytic enzymes in multiple myeloma”
Sakalova A, Kunze R, Holomanova D, Hapalova J, Chorvath B, Mistrik M, Sedlak J.
Vnitr Lek. 1995 Dec;41(12):822-6.
12 - “Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations”
Desser L, Rehberger A, Kokron E, Paukovits W.
Oncology. 1993 Nov-Dec;50(6):403-7.
13 -" The Original Metabolic Medicine’s Cancer Cure: One answer to cancer"
By Dr. William Donald Kelley, D.D.S., M.S.
14 - "A Critique of the Kelley Nutritional-Metabolic Cancer Program"
by Melina A. Roberts BSc. (Hons.)
ENZIMAS PARA EL TRATAMIENTO DE ENFERMEDADES REUMATICAS
15 - “Proteolytic enzymes as an alternative in comparison with nonsteroidal anti-inflammatory drugs (NSAID) in the treatment of degenerative and inflammatory rheumatic disease: systematic review”
Heyll U, Munnich U, Senger V.
Med Klin (Munich). 2003 Nov 15;98(11):609-15.
16 - “Therapy with proteolytic enzymes in rheumatic disorders”
Leipner J, Iten F, Saller R.
BioDrugs. 2001;15(12):779-89.
17 - “Circulating immune complexes and complement fragment iC3b in chronic polyarthritis during 12 months therapy with oral enzymes in comparison with oral gold”
Kullich W, Schwann H.
Wien Med Wochenschr. 1992;142(22):493-7.
ENZIMAS PARA EL TRATAMIENTO DEL AUTISMO
18 - “Enzyme-based therapy for autism spectrum disorders -- is it worth another look?”
Brudnak MA, Rimland B, Kerry RE, Dailey M, Taylor R, Stayton B, Waickman F, Waickman M, Pangborn J, Buchholz I.
Med Hypotheses. 2002 May;58(5):422-8
Oncology. 1993 Nov-Dec;50(6):403-7.
|
